T1	Participants 1564 1728	CONCLUSIONS Retapamulin ointment 1% (bid) for 5 days was as effective as oral cephalexin (bid) for 10 days in treatment of patients with SID, and was well tolerated
T2	Participants 853 972	RESULTS Retapamulin was as effective as cephalexin (clinical success rates at follow-up: 85.9% and 89.7%, respectively)
T3	Participants 544 695	METHODS Patients with SID were randomly assigned to retapamulin ointment 1% (twice daily [bid]) for 5 days, or oral cephalexin (500 mg bid) for 10 days
T4	Participants 394 542	OBJECTIVE We sought to determine the clinical safety and efficacy of topical retapamulin ointment 1% versus oral cephalexin for the treatment of SID
T5	Participants 207 391	BACKGROUND New antibacterial agents with activity against pathogenic strains resistant to established antibiotics are needed to treat patients with secondarily infected dermatitis (SID
